noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

United States Attorney's Office[...]

Repeat Offender Sentenced to 20 Years’ Imprisonment for His Ninth[...]
U.S. Department of Health & Human[...]

HHS Awards More Than $11 Million to Expand Medical Residencies in Rural[...]
LivePerson Inc.

Post-effective Amendment to Registration Statement for Employee Benefit[...]

Healthcare

BioCorRx Inc.

09/04/2026 | Press release | Distributed by Public on 09/04/2026 07:54

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of Director

On August 31, 2026, Kate Beebe DeVarney, Ph.D. submitted her resignation from her position as a member of the board of directors (the "Board") of BioCorRx Inc.(the "Company"), effective August 31, 2026 (the "DeVarney Resignation").

The DeVarney Resignation did not arise as a result of any disagreement with the Company nor BioCorRx Pharmaceuticals, a subsidiary of the Company.

BioCorRx Inc. published this content on September 04, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on September 04, 2026 at 13:54 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format